Mark C. Schneyer Acadia Pharmaceuticals Inc (ACAD) insider trading activity

ACAD Quotes by TradingView

Mark C. Schneyer is EVP, CHIEF FINANCIAL OFFICER of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 62,130 shares of ACAD, which is worth approximately $1.33 Million. The most recent transaction as insider was on Aug 21, 2023, when has been sold 10,000 shares (Common Stock) at a price of $29.0 per share, resulting in proceeds of $290,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.1K
15.31% 3M change
74.82% 12M change
Total Value Held $1.33 Million

Mark C. Schneyer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 21 2023
SELL
Open market or private sale
$290,000 $29.0 p/Share
10,000 Reduced 38.94%
15,682 Common Stock
Jun 08 2023
SELL
Open market or private sale
$24,369 $25.02 p/Share
974 Reduced 4.09%
22,824 Common Stock
Jun 08 2023
BUY
Exercise of conversion of derivative security
-
1,893 Added 7.37%
23,798 Common Stock
May 17 2023
SELL
Open market or private sale
$344,475 $22.5 p/Share
15,310 Reduced 41.14%
21,905 Common Stock
May 17 2023
BUY
Exercise of conversion of derivative security
-
29,738 Added 44.42%
37,215 Common Stock
Apr 06 2023
SELL
Open market or private sale
$34,794 $18.16 p/Share
1,916 Reduced 20.4%
7,477 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
-
5,275 Added 35.96%
9,393 Common Stock
Feb 24 2023
SELL
Open market or private sale
$10,836 $18.78 p/Share
577 Reduced 12.29%
4,118 Common Stock
Feb 23 2023
BUY
Exercise of conversion of derivative security
-
1,353 Added 22.37%
4,695 Common Stock
Jun 09 2022
SELL
Open market or private sale
$11,695 $17.91 p/Share
653 Reduced 16.35%
3,342 Common Stock
Jun 08 2022
BUY
Exercise of conversion of derivative security
-
1,893 Added 32.15%
3,995 Common Stock
Feb 23 2022
SELL
Open market or private sale
$13,161 $23.8 p/Share
553 Reduced 20.83%
2,102 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
-
1,352 Added 33.74%
2,655 Common Stock
MCS

Mark C. Schneyer

EVP, CHIEF FINANCIAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACAD